YTHDF3 and prostate adenocarcinoma: We also used the "Pathological Stage Map" and "Age" modules to observe the correlation between YTHDF3 expression and cancer pathological stage, including the expression of YTHDF3 in Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), PRAD, LGG, GBMLGG, LUAD, STAD, Ovarian serous cystadenocarcinoma (OV), and Kidney renal clear cell carcinoma (KIRC).